INSIGHTBIO, S.A. was established to provide international pharmaceutical sponsors with a reliable, GCP-compliant Phase I unit in Latin America — combining scientific excellence with operational efficiency.
With over a decade of pharmaceutical and clinical research experience, INSIGHTBIO, S.A. has grown from a scientific consulting practice into a fully-equipped, dedicated Phase I clinical research unit.
We are registered in the Republic of Panama and operate under full ICH E6(R2) Good Clinical Practice compliance.
Our purpose-built Phase I facility integrates clinical care, analytical science, and data management under one roof.
Dedicated inpatient beds for 24-hour confinement studies. Separate rooms for drug dispensing, dosing observation, and post-dose monitoring.
On-site ICU with a physician on duty around the clock. Full resuscitation equipment and emergency response protocols.
In-house laboratory: hematology, biochemistry, urinalysis, coagulation. Certified sample storage with full chain-of-custody documentation.
Electronic synchronized timekeeping for precise PK sample time recording. Video surveillance and volunteer call system.
Dedicated IP storage with temperature monitoring, restricted access, and full dispensing accountability log.
On-site nutrition service by a qualified nutritionist — standardized meals per protocol diet for fasting, fed-state, and high-fat meal studies.
Every aspect of our operations is governed by ICH E6(R2) GCP guidelines. All clinical staff hold current GCP certification. Principal Investigators are board-certified physicians with Phase I trial experience.
INSIGHTBIO operates with an established Independent Ethics Committee (IEC) that reviews and approves Phase I studies at our site. IEC submission timelines: typically 3–4 weeks for standard Phase I protocols, with expedited review available for time-sensitive programs.
Panama City — a regional and international hub with direct flights to North America, Europe, Asia, and South America.
Streamlined regulatory and IEC pathways in Panama enable faster site activation compared to many Western markets.
Panama operates with the US Dollar — eliminating foreign exchange risk for international sponsors.
Panama's multicultural population provides access to healthy volunteer cohorts with diverse genetic backgrounds — valuable for ethnobridging studies.
Legal Name
INSIGHTBIO, S.A.
Jurisdiction
Republic of Panama
Commercial Registry
Folio Mercantil 155784529
Regulatory Standard
ICH E6(R2) GCP
International Clients
UAE · Hong Kong · USA
EDC Partners
Medidata · CRIO
Send us your study synopsis and we will provide a rapid feasibility assessment — including site capabilities, volunteer recruitment strategy, and indicative timeline and budget.
Request a Feasibility Assessment